Next-gen technologies such as AI and ML are the most prominent drivers for the life sciences BPO market.
Next-gen technologies such as AI and ML are the most prominent drivers for the life sciences BPO market. Data-driven technologies are offering biopharma and medtech organizations with actionable insights and helping them to automate mundane tasks. The recent outbreak of COVID-19 is another key driver generating value-grab opportunities for CROs.
Companies are developing platforms with workflow-enabled issue management that helps clients to lower risks of associated with clinical trials. However, challenges such as the need to rethink customer experience and compliance with industry standards poses as a barrier for market growth. Hence, companies should aim toward blockchain-powered applications to enhance compliance and improve consumer experience.
Life Sciences BPO market: Overview
- According to Transparency Market Research’s latest research report on the global life sciences BPO market for the historical period from 2017 to 2018 and the forecast period from 2019 to 2027, rise in demand for low cost drugs, patent expirations, and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This is projected to drive the global life sciences BPO market during the forecast period.
- According to the report, the global life sciences BPO market was valued at ~US$ 214 Bn in 2018 and is anticipated to expand at a CAGR of ~8% from 2019 to 2027
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1782
Technological Advancements in Life Sciences BPO: A Key Driver
- In the current market scenario, strategic outsourcing services play an important role in addressing various challenges faced by pharmaceutical companies such as stagnant productivity volume, regulatory changes, pricing pressures, and thinner profit margins
- Strategic outsourcing has become an industry norm and offers a range of services from screening and lead identification to toxicology, pre-clinical studies, clinical trials, manufacturing, and marketing. The pharmaceutical outsourcing market, particularly CMOs and CROs, has evolved in the past few years and expected to witness strong growth in the next decade.
- Outsourcing has become a feasible and beneficial business strategy for pharmaceutical, biotechnology, and life sciences industries, enabling transfer of non-core activities to outsourcing partners in order to focus on distribution networks, competitive advantage, future growth, marketing strategies, and issues imperative for survival. Rise in cost of R&D, decline in productivity, and patent expirations boost the growth of the global life sciences BPO market.
Request for Analysis of COVID19 Impact on Life Sciences BPO Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1782
Globalization of Drug Development with Shift of Manufacturing Units from High Cost to Low Cost Regions
- The continuous changing market dynamics have compelled the pharmaceutical companies to remodel their existing operations. The focus has shifted toward globalization of the drug development process. The global competitive environment has led to streamlining of manufacturing operations, R&D, medical writing, clinical data management, and other processes.
- Outsourcing the clinical trial process to contract research units facilitates evaluation of drugs in multiple locations in parallel, thereby producing data, which originates from a large and varied patient pool. This is considered one of the major advantages of research outsourcing.
- Hence, globalization coupled with budget restraints has compelled the drug manufacturers to opt for low cost regions for outsourcing their R&D, clinical trials, and data management services. This in turn is anticipated to boost the global life sciences BPO market during the forecast period.
Stringent Regulatory Approval Processes in Different Countries to Hamper Life Sciences BPO Market
- Majority of the clinical trials and other research processes are outsourced to various countries simultaneously. These destination countries have different guidelines and regulatory processes related to drugs, filing, and clinical trials.
- The conduction of multi-location trials of a single drug in different procedures in different countries poses a challenge to pharmaceutical companies, as these have to follow a completely different procedure in each country. This is considered one of the major challenges for research outsourcing in different countries. Therefore, a company prefers to restrict outsourcing to one destination country.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1782
Life Sciences BPO Market: Competition Landscape
- This report profiles major players operating in the global life sciences BPO market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global life sciences BPO market is highly fragmented, with large number of players in the global market and small-scale players in regional markets. The top four to five players hold major share of the global life sciences BPO market.
- Prominent players operating in the global life sciences BPO market are
- IQVIA
- Laboratory Corporation of America Holdings
- Syneos Health, Inc.
- Parexel International Corporation
- PRA Health Sciences, Inc.
- Charles River Laboratories International, Inc.
- WuXi AppTec Co., Ltd.
- ICON plc
- Medpace Holdings, Inc.
- Pharmaceutical Product Development, LLC.
Buy Life Sciences BPO Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=1782<ype=S
Life Sciences BPO Market: Key Developments
- Key players operating in the global life sciences BPO market are engaged in the development and approval of new products, mergers & acquisitions, and collaborations. Major strategies adopted by the key players are likely to fuel the global life sciences BPO market in the next few years. Key developments in the global life sciences BPO market are:
- In June 2018, Laboratory Corporation of America Holdings acquired Sciformix Corporation, a scientific process outsourcing company engaged in offering pharmacovigilance and regulatory solutions to biopharmaceutical and medical device companies. The acquisition strengthened the company’s position in the later phases of drug and device development, primarily for post-marketing pharmacovigilance and market access solutions.
- In September 2017, Laboratory Corporation of America Holdings acquired Chiltern, which became a part of the company’s CDD segment. This acquisition enabled the former to strengthen its position in the global CRO services market.
- Syneos Health, Inc. entered into several partnerships to consolidate its position in the market and expand its customer base. For instance, in November 2019, the company entered into a partnership with AiCure, an AI and advanced data analytics company, to optimize patient engagement and trial success.
- The report on the global life sciences BPO market discusses individual strategies, followed by company profiles of manufacturers of life sciences BPO. The competition landscape section has been included in the report to provide readers with a dashboard view and company market share analysis of the key players operating in the global life sciences BPO market.
Browse More Trending Reports by Transparency Market Research:
Plasma Feed Market: https://www.transparencymarketresearch.com/plasma-feed-market.html
Synthetic Hormones Market: https://www.transparencymarketresearch.com/synthetic-hormones-market.html
Achondroplasia Treatment Market: https://www.transparencymarketresearch.com/achondroplasia-treatment-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453